Učitavanje...
Immune checkpoint inhibitors: Real-world experience from India in advanced solid cancers that have progressed on chemotherapy
CONTEXT: The immune checkpoint inhibitors (ICIs) nivolumab and pembrolizumab have shown dramatic efficacy with low toxicity in international studies of advanced solid cancers. No published Indian experience with ICIs exist other than isolated case reports. AIMS: The aim of this study is to evaluate...
Spremljeno u:
| Izdano u: | South Asian J Cancer |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Medknow Publications & Media Pvt Ltd
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6348784/ https://ncbi.nlm.nih.gov/pubmed/30766859 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/sajc.sajc_167_18 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|